Oskar Hansson
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, Parkinson's Disease Mechanisms and Treatments, Advanced Neuroimaging Techniques and Applications
Most-Cited Works
- → Donanemab in Early Symptomatic Alzheimer Disease(2023)2,260 cited
- → Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup(2024)1,822 cited
- → Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study(2006)1,682 cited
- → Brain charts for the human lifespan(2022)1,672 cited
- → Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders(2020)1,438 cited
- → Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts(2020)1,309 cited